M-30 and 4HNE are sequestered in different aggresomesin the same hepatocytes

Experimental and Molecular Pathology

Volumn 83, Issue 3, 2007, Pages 296-300

  Amidi, Fataneh ^a   French, Barbara A ^a   Chung, David ^a   Halsted, Charles H ^b   Medici, Valentina ^b   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aggresomes; Caspase 3; Mallory Denk bodies; Oxidative stress; Steatohepatitis

Indexed keywords

4 HYDROXYNONENAL;

AGGRESOME; ALCOHOL LIVER DISEASE; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER BIOPSY; LIVER CELL; LIVER CELL DAMAGE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS;

EID: 36048976016     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.09.001     Document Type: Article

References (23)

1. Bantel H., Ruck P., Gregor M., and Schulze-Oshoff K. Detection of elevated caspase activation and early apoptosis in liver disease. Eur. J. Cell Biol. 80 (2001) 230-239
2. Bantel H., Lugering A., Heidemann J., Volkmann X., Poremba C., Strassburg C.P., Manns M.P., and Schultze-Osthoff K. Detection of apoptotic caspase activation in sera from patients with chronic HCV, infection is associated with fibrotic liver injury. Hepatology 40 (2004) 1078-1082
3. Bardag-Gorce F., Li J., French B.A., and French S.W. The effect of ethanol-induced CYP2E1 on proteasome activity: the role of 4-hydroxynonenal. Exp. Mol. Pathol. 78 (2005) 109-115
4. Bardag-Gorce F., French B.A., Nan L., Song H., Nguyen S.K., Yong H., Dedes J., and French S.W. CYP2E1 induced by ethanol causes oxidative stress and protease inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp. Mol. Pathol. 81 (2006) 191-201
5. Caulin C., Salversen G.S., and Oshima R.G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 138 (1997) 1379-1394
6. Chedid A., Mendenhall C.L., Gartside P., French S.W., Chu T., and Rabain L. Alcoholic liver disease. Prognostic factors according to stage. Am. J. Gastroenterol. 86 (1991) 210-216
7. Esterbauer H., Schaur R.J., and Zoliner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic. Biol. Med. 11 (1992) 81-128
8. French S.W., Wong K., Jui L., Albino E., Hagbjork A.L., and Ingelman-Sundberg M. Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation and serum protein adduct formation in relation to liver pathology pathogenesis. Exp. Mol. Pathol. 58 (1993) 61-75
9. French S.W., Nash J., Shitabata P., Kachi K., Hara C., Chedid A., and Mendenhall C. Pathology of alcoholic liver disease. Semin. Liver Dis. 13 (1993) 154-169
10. Ishii H., Adachi M., Fernandez-Checa J.C., Cederbaum A.I., Deaciuc I.V., and Nanji A.A. Role of apoptosis in alcoholic liver injury. Alcohol Clin. Exp. Res. 27 (2003) 1207-1212
11. Ku N.O., Liso J., and Omary M.B. Apoptosis generates stable fragments of human type 1 keratins. J. Biol. Chem. 272 (1997) 33197-33203
12. Leers M.P., Kolgen W., Bjorklund V., Bergman T., Tribbick G., Persson B., Bjorklund P., Ramaeters F.C., Bjorklund B., Nap M., Jornvall H., and Schutte B. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitopic exposed during early apoptosis. J. Pathol. 187 (1999) 567-572
13. Li C.J., Nanji A.A., Siakotos A.N., and Lin R.C. Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the liver of rats with alcoholic liver disease. Hepatology 26 (1997) 650-657
14. MacFarlane M., Merrison W., Dinsdale O., and Cohen G.M. Activate caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J. Cell Biol. 148 (2000) 1239-1254
15. Mottaran E., Stewart S.F., Rolla R., Vay D., Cipriani V., Moretti M., Vidali M., Sartori M., Rigamonti C., Day C.P., and Albino E. Lipid peroxidation contributors to immune reactions associated with alcoholic liver disease. Free Radic. Biol. Med 32 (2002) 38-43
16. Seki S., Kitada T., Yamada J., Sakaguchi H., Nakatini K., and Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J. Hepatol. 37 (2002) 56-62/
17. Seki S., Kitada T., Sakaguchi H., Nakatani K., and Wakasa K. Pathological significance of oxidative cellular damage in human alcoholic liver disease. Histopathology 42 (2003) 365-371
18. Ueno T., Toi M., and Linder S. Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed. Pharmacother. 59 Suppl. 2 (2005) S359-S362
19. Wieckowska A., Zern N.W., Yerian L.M., Lopez A.R., McCullough A.J., and Feldstein A.E. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44 (2006) 27-33
20. Petersen D.R., and Doom J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol. Med. 37 (2004) 937-945
21. Willner I.R., and Reuben A.B. Alcohol and the liver. Curr. Opin. Gastroenterol. 21 (2005) 323-330
22. Yasumi Y., Takikawa Y., Endo R., and Suzuki K. Significance of a novel biomarker for hepatocellular apoptosis (caspase 3-cleaved cytokeratin-18 product) in acute and fulminating hepatic injury. Gastroenterology 132 (2007) A87
23. Yimaz Y., Dolan E., Ulukaya E., Akgoz S., Keskin M., Kiyici M., Aker S., Yilmaztepe A., Gorel S., Gulten M., and Nak S.G. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J. Gastroenterol. 14 (2007) 837-844